PharmaEngine Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 3, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	9,023	12,974	15,158	17,961	10,207	8,430
Market Cap Growth	-39.03%	-14.41%	-15.60%	75.96%	21.08%	-15.52%
Enterprise Value	4,435	9,241	11,619	14,348	6,496	5,058
Last Close Price	62.80	83.35	95.67	110.57	62.24	47.53
PE Ratio	5.40	7.41	55.19	56.34	23.96	13.95
Forward PE	23.19	10.91	42.71	150.60	38.52	109.54
PS Ratio	3.60	5.14	19.75	27.45	15.59	7.98
PB Ratio	1.88	2.40	3.92	4.64	2.59	2.10
P/TBV Ratio	1.88	2.40	3.93	4.64	2.59	2.10
P/FCF Ratio	5.25	28.46	59.08	90.45	10.98	130.16
P/OCF Ratio	5.25	28.41	58.99	88.91	10.98	130.16
EV/Sales Ratio	1.77	3.66	15.14	21.93	9.92	4.79
EV/EBITDA Ratio	2.17	4.50	41.71	50.62	17.88	6.23
EV/EBIT Ratio	2.18	4.50	41.92	50.75	17.91	6.25
EV/FCF Ratio	2.58	20.27	45.29	72.26	6.99	78.09
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.00	0.01
Debt / EBITDA Ratio	0.00	0.00	0.05	0.08	0.02	0.03
Debt / FCF Ratio	0.00	0.02	0.06	0.11	0.01	0.34
Net Debt / Equity Ratio	-0.96	-0.71	-0.93	-0.94	-0.97	-0.84
Net Debt / EBITDA Ratio	-2.26	-1.87	-12.97	-12.84	-10.47	-4.16
Net Debt / FCF Ratio	-2.67	-8.45	-14.08	-18.33	-4.09	-52.06
Asset Turnover	0.56	0.52	0.19	0.16	0.16	0.27
Inventory Turnover	3.15	2.16	1.94	2.50	2.46	1.52
Quick Ratio	43.26	13.07	46.50	49.34	45.57	22.41
Current Ratio	43.53	13.15	46.78	49.86	45.71	22.61
Return on Equity (ROE)	38.17%	37.81%	7.10%	8.16%	10.72%	16.13%
Return on Assets (ROA)	28.33%	26.18%	4.37%	4.42%	5.51%	12.89%
Return on Invested Capital (ROIC)	-	185.11%	93.31%	125.60%	73.39%	175.80%
Return on Capital Employed (ROCE)	42.40%	38.00%	7.20%	7.30%	9.20%	20.10%
Earnings Yield	18.56%	13.50%	1.81%	1.77%	4.17%	7.17%
FCF Yield	19.05%	3.51%	1.69%	1.11%	9.11%	0.77%
Dividend Yield	9.36%	7.20%	1.57%	1.81%	4.34%	5.26%
Payout Ratio	51.46%	12.30%	104.57%	121.62%	85.44%	12.05%
Buyback Yield / Dilution	-0.17%	-0.13%	-0.03%	0.72%	0.80%	-0.11%
Total Shareholder Return	9.06%	7.07%	1.54%	2.53%	5.13%	5.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.